Prevalence and Outcome of Serum Autoantibodies in Chronic Hepatitis C Patients Undergoing Direct-Acting Antiviral Treatment

BACKGROUND: Chronic immune stimulation by hepatitis C virus (HCV) may cause occurrence of several autoantibodies in infected patients, with or without features of clinically overt autoimmune diseases. The recent introduction of direct-acting antivirals (DAAs) has dramatically changed the natural his...

Descripción completa

Detalles Bibliográficos
Autores principales: Romano, Ciro, Tortorella, Olga, Dalla Mora, Liliana, Di Stasio, Dario, Sellitto, Ausilia, Adinolfi, Luigi Elio, Marrone, Aldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038215/
https://www.ncbi.nlm.nih.gov/pubmed/35479086
http://dx.doi.org/10.3389/fimmu.2022.882064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038215/
https://www.ncbi.nlm.nih.gov/pubmed/35479086
http://dx.doi.org/10.3389/fimmu.2022.882064

Ejemplares similares